
News|Articles|January 1, 2002
Real-world study finds "unequivocal"lack of difference among SSRIs
The selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline,and paroxetine are equally effective and tolerated in depressed patientsacross a broad range of outcome measures. So finds an open-label, randomizedstudy in 573 patients treated for depression for 9 months in a primary caresetting.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
New self-injectable biologics promise cost savings and patient convenience
2
World AIDS Day: 10 things to know about AIDS in 2025
3
HS patients on biosimilar adalimumab lose response faster than those on the original drug
4
Exploring Recent Guideline Updates on the Management of Hyperlipidemia | Written Recap
5






















































